Skip to main content

Advertisement

Log in

C5α secreted by tumor mesenchymal stem-like cells mediates resistance to 5-aminolevulinic acid-based photodynamic therapy against glioblastoma tumorspheres

  • Research
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose

Advancements in photodynamic diagnosis (PDD) and photodynamic therapy (PDT) as a standard care in cancer therapy have been limited. This study is aimed to investigate the clinical availability of 5-aminolevulinic acid (5-ALA)-based PDD and PDT in glioblastoma (GBM) patient-derived tumorspheres (TSs) and mouse orthotopic xenograft model.

Methods

PDT was performed using a 635 nm light-emitting diode (LED). Transcriptome profiles were obtained from microarray data. For knockdown of C5α, siRNA was transfected into tumor mesenchymal stem-like cells (tMSLCs). The invasiveness of TSs was quantified using collagen-based 3D invasion assays.

Results

Treatment with 1 mM 5 ALA induced distinct protoporphyrin IX (PpIX) fluorescence in GBM TSs, but not in non-tumor cells or tissues, including tMSLCs. These observations were negatively correlated with the expression levels of FECH, which catalyzes the conversion of accumulated PpIX to heme. Furthermore, the 5-ALA-treated GBM TSs were sensitive to PDT, thereby significantly decreasing cell viability and invasiveness. Notably, the effects of PDT were abolished by culturing TSs with tMSLC-conditioned media. Transcriptome analysis revealed diverse tMSLC-secreted chemokines, including C5α, and their correlations with the expression of stemness- or mesenchymal transition-associated genes. By adding or inhibiting C5α, we confirmed that acquired resistance to PDT was induced via tMSLC-secreted C5α.

Conclusions

Our results show substantial therapeutic effects of 5-ALA-based PDT on GBM TSs, suggesting C5α as a key molecule responsible for PDT resistance. These findings could trigger PDT as a standard clinical modality for the treatment of GBM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Data availability

The data sets supporting the conclusions of this article are available in the Gene Expression Omnibus repository at https://www.ncbi.nlm.nih.gov/geo/, GSE159000 (GBM TSs) and GSE131837 (GBM tissues) (Park et al. 2019). Gene expression profiles of other samples, including NHAs, BM–MSCs, and tMSLCs, are available from the corresponding author upon reasonable request.

References

Download references

Funding

This study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government Ministry of Science and ICT (NRF-2022R1A2B5B03001199, NRF-2020M2D9A2092372, NRF-2020M3E5E2037960, NRF-2017R1C1B2003686); Ministry of Education (NRF-2021R1I1A1A01048717); Team Science Award of Yonsei University College of Medicine (6-2021-0192).

Author information

Authors and Affiliations

Authors

Contributions

Conceptualization: JP and S-GK; methodology: JP, J-KS, SJO, and YBJ; software: JP; validation: JP, J-KS, SJO, and YBJ.; formal analysis: JP and YBJ; investigation: JP and YBJ; resources: SJO, JHM, EHK, JHC, and S-JL; data curation: JP, J-KS, and SJO; writing—original draft: JP; writing—review and editing: S-GK; visualization: JP; project administration: Y-MH, J-SS, and S-GK; funding acquisition: JP and S-GK.

Corresponding author

Correspondence to Seok-Gu Kang.

Ethics declarations

Competing interests

The authors declare no competing interests.

Conflict of interest

The authors have no relevant financial or non-financial interests to disclose.

Ethical approval

Experiments in this study were conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Review Board of Severance Hospital, Yonsei University College of Medicine (4-2012-0212, 4-2014-0649). All in vivo experimental procedures were approved by the Yonsei University College of Medicine Institutional Animal Care and Use Committee (2017-0347) and adheres to the ARRIVE guidelines.

Consent to participate

Written informed consent was received from participants prior to inclusion in the study.

Consent to publish

Written informed consent was received from participants for publication.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 1630 KB)

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Park, J., Oh, S.J., Shim, JK. et al. C5α secreted by tumor mesenchymal stem-like cells mediates resistance to 5-aminolevulinic acid-based photodynamic therapy against glioblastoma tumorspheres. J Cancer Res Clin Oncol 149, 4391–4402 (2023). https://doi.org/10.1007/s00432-022-04347-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-022-04347-w

Keywords

Navigation